Serotonin 5-HT2C Receptor Antagonists
DBCAT005169Pharmacologic class
Entities that are capable of exerting an antagonistic effect on 5-HT2C receptors. A DrugBank category of 56 drugs. 47 of them are approved.
What you can answer from here — as of July 02, 2020
Which targets do Serotonin 5-HT2C Receptor Antagonists share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account